SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global Lifescience Reagent Market was valued at US$ 33,754.0 million in 2017 and is projected to exhibit a CAGR of 7.3% during the forecast period (2018–2026).
Key Trends and Analysis of the Global Lifescience Reagent Market:
Manufacturers are engaged in developing biological reagents for various research purposes, which is expected to drive the global lifescience reagents market growth. For instance, in June 2014, Bio-Rad laboratories, Inc. launched SsoAdvanced Preamp Supermix and Primepcr Preamp Assays. The new reagent, ssoadvanced preamp supermix, has been formulated to permit unbiased, target-specific preamplification of cDNA or genomic DNA (gDNA), allowing researchers to stretch their limited nucleic acid samples. Primepcr PreAmp assays are wet-lab validated preamplification primers that work with the supermix to ensure optimal preamplification for real-time polymerase chain reaction (PCR)
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2681
Moreover, in April 2019, Quantabio launched the Qscript lyo 1-step, a lyophilized single-reaction reagent, optimized for highly sensitive and reproducible RT-qPCR RNA applications. The freeze-dried Qscript lyo 1-step master can be stored up to nine months at ambient temperatures or two years at 4 degrees Celsius from the manufacturing date. Moreover, in February 2019, Thermo Fisher Scientific launched its CytoVista tissue clearing reagents, which are designed for use with both 3D cell culture models as well as whole tissues. The CytoVista tissue clearing technology sufficiently clears tissue for 3D fluorescent imaging.
Increasing acquisitions among the biotechnology industry players is contributing to global lifescience reagent market share. For instance, in February 2017, Anatrace (StoneCalibre’s portfolio company), acquired Molecular Dimensions Ltd. Molecular Dimensions Ltd is the U.K.-based supplier of modern screens, reagents, and other consumables and instrumentation for structural biology research. With this acquisition, Anatrace intended to establish its presence in Europe and expand its position in the structural biology product portfolio.
Europe is expected to show significant market growth rate, owing to increasing initiatives by the key players in this region. For instance, in 2014, Biofortuna, a U.K.-based provider of high quality IVD development and custom manufacturing services, expanded its PCR reagent lyophilization production service to meet increasing demand for diagnostic kits containing freeze-dried reagents in the emerging market.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/lifescience-reagent-market-2681
Key Market Takeaways:
- The global lifescience reagent market is projected to witness CAGR of 7.3% during the forecast period (2018–2026), owing to increasing product launches of lifescience reagents. For instance, in October 2017, Sysmex America Inc. launched CyFlow Antibodies, a comprehensive portfolio of Analyte Specific Reagent (ASR) antibodies for the use in flow cytometry applications. It boasts monoclonal antibodies with high Mean Fluorescent Intensity (MFI) and dependable lot-to-lot consistency.
- Among region, North America is expected to show significant growth in global lifescience reagent market, owing to increasing initiatives by key players involved in lifescience research purpose. For instance, in May 2017, Avacta gave exclusive rights to two U.S-based biotech companies (names not disclosed) to use Affimer reagents for research and development purpose, which supports their respective drug development programs. Affimer reagents were developed by the Avacta.
- Major players operating in the global lifescience reagent market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories, GE Healthcare, Siemens Healthineers, Becton, Dickinson and Company, Agilent Technologies Inc., Perkin Elmer Inc., Waters Corporation, Ortho Clinical Diagnostics, bioMérieux SA, and Sysmex Corporation
Buy this exclusive Business report now @ https://www.coherentmarketinsights.com/insight/buy-now/2681
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
